SPOTLIGHT -
FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma
Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.
Food Insecurity and the Dangers of Infant Formula Dilution
Zolgensma Yields 100% Bulbar Function Response in Presymptomatic SMA
All children included in the analysis achieved swallowing, oral nutrition, and airway protection outcomes.
Demystifying Infant Formula
Pediatric speech disorder diagnoses more than doubled amid COVID-19 pandemic
Recent data revealed a 110% increase in speech disorder diagnoses for children aged 0 to 12 years in 2022, compared to the pre-pandemic era.
Earlier HPV vaccination associated with completed vaccine series
In a recent review, children with vaccination against human papillomavirus (HPV) initialized at a younger age were more likely to receive their full vaccination series.
